CoraLite®594-conjugated Alpha 1 antichymotrypsin Monoclonal antibody

• 

  IF Staining of human tonsillitis using CL594-66078

  Immunofluorescent analysis of (4% PFA) fixed human tonsillitis tissue using CL594-66078 (alpha 1 Antichymotrypsin antibody) at dilution of 1:50.

Alpha 1 antichymotrypsin Monoclonal Antibody for IF-P

Cat No. CL594-66078

Clone No.3F2F10

Host / Isotype

Mouse / IgG2b

Reactivity

human

Applications

IF-P

Synonyms

Alpha Antichymotrypsin, SERPINA3, ACT, AACT, A-1-Antichymotrypsin

---

Tested Applications

• Positive IF-P detected in: human tonsillitis tissue

Recommended dilution

• Immunofluorescence (IF)-P: IF-P : 1:50-1:500

It is recommended that this reagent should be titrated in each testing system to obtain optimal results.

Sample-dependent, Check data in validation data gallery.

Product Information

CL594-66078 targets Alpha 1 antichymotrypsin in IF-P applications and shows reactivity with human samples.

• Tested Reactivity: human
• Host / Isotype: Mouse / IgG2b
• Class: Monoclonal
• Type: Antibody
• Immunogen: Alpha 1 antichymotrypsin fusion protein Ag2830
• Full Name: serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 3
• Calculated Molecular Weight: 448 aa, 48 kDa
• Observed Molecular Weight: 60 kDa
• GenBank Accession Number: BC010530
• Gene Symbol: Alpha 1 Antichymotrypsin
• Gene ID (NCBI): 12
• RRID: AB_2883504
• Conjugate: CoraLite®594 Fluorescent Dye
• Excitation/Emission Maxima Wavelengths: 588 nm / 604 nm
• Form: Liquid
• Purification Method: Protein A purification
• UNIPROT ID: P01011
• Storage Buffer: PBS with 50% Glycerol, 0.05% Proclin300, 0.5% BSA, pH 7.3.
• Storage Conditions: Store at -20°C. Avoid exposure to light. Stable for one year after shipment. Aliquoting is unnecessary for -20^oC storage.

Background Information

Human SerpinA3, also known as Alpha 1-antichymotrypsin (AACT), is a member of the serine protease inhibitor class, and is a plasma alpha globulin glycoprotein which increases in the blood during the inflammatory process. SerpinA3, is also an inhibitor of neutrophil cathepsin G, mast cell chymases and pancreatic chymotrypsin. SerpinA3 is produced primarily in the liver, and is identified as an acute-phase inflammatory protein. SerpinA3 deficiency has been associated with liver disease. SerpinA3 has also been implicated in the pathology of a number of devastating human diseases including chronic obstructive pulmonary disease (COPD), Parkinson's disease (PD), Alzheimer's disease (AD), Stroke, Cystic Fibrosis, Cerebral Haemorrhage and Multiple System Atrophy.